Santen Pharmaceutical Co Ltd SNPHF
Trading Information
- Previous Close Price
- $13.05
- Day Range
- $11.00–11.00
- 52-Week Range
- $8.88–13.06
- Bid/Ask
- $0.01 / $411.60
- Shares Outstanding
- 321.28M
- Market Cap
- $3.54B
- Volume/Avg
- 500 / 4,244
Key Statistics
- Price/Earnings (Normalized)
- 14.30
- Price/Sales
- 1.89
- Dividend Yield (Trailing)
- 2.28%
- Dividend Yield (Forward)
- 2.44%
- Dividend Payment Schedule
- Jun, Nov
- Total Yield
- 8.39%
Company Profile
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,968
- Website
- https://www.santen.com
Valuation
|
Metric
|
SNPHF
|
|---|---|
Price/Earnings (Normalized) | 14.30 |
Price/Book Value | 1.91 |
Price/Sales | 1.89 |
Price/Cash Flow | 9.27 |
Price/Earnings
SNPHF
Financial Strength
|
Metric
|
SNPHF
|
|---|---|
Quick Ratio | 1.86 |
Current Ratio | 2.82 |
Interest Coverage | 24.38 |
Quick Ratio
SNPHF
Profitability
|
Metric
|
SNPHF
|
|---|---|
Return on Assets (Normalized) | 9.55% |
Return on Equity (Normalized) | 13.54% |
Return on Invested Capital (Normalized) | 11.25% |
Return on Assets
SNPHF
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|j>TYXvNP | LOCK|s! | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|@jsm>&? | LOCK|Mv^ | $635B | |||
| AbbVie Inc
ABBV
| LOCK|Hj$zN!X | LOCK|#b | $505B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|N>P>Fh$ | LOCK|HT | $381B | |||
| Merck & Co Inc
MRK
| LOCK|dS##x$J | LOCK|V#z | $358B | |||
| Novartis AG ADR
NVS
| LOCK|$ghk!#b% | LOCK|H< | $297B | |||
| AstraZeneca PLC
AZN
| LOCK|&J!H$l&M | LOCK|>!# | $267B | |||
| Amgen Inc
AMGN
| LOCK|QZW>Kdwd | LOCK|#Y | $237B | |||
| Gilead Sciences Inc
GILD
| LOCK|S?^By$% | LOCK|%yD | $193B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|S>#x!k? | LOCK|D@X | $172B |
United States